Table 1

Outcome measures between baseline and 3 months

OutcomeMeasurement
Primary
 Cost-effectivenessStandard treatment costs and health service utilisation
ΔHealth-related quality of life (SRI14 15 questionnaire and EQ-5D)
 Clinical effectivenessΔPaCO2 between baseline and 3 months
Secondary
Patient-centred
 SymptomsMedical Research Council dyspnoea score;16 Epworth sleepiness score;17 HAD score18
 Proxy healthcare-related quality of lifeEQ-5D-5 L by partner and/or carer
 Body compositionWeight Loss, BMI, fat mass, fat-free mass, fat-free mass index, neck circumference (cm), chest circumference (cm), waist circumference (cm), hip circumference (cm), waist-to-hip ratio
 Non-invasive ventilation adherenceHours per night use
Physician-centred
 Daytime gas exchangePaO2, PaCO2, pH, HCO3, packed cell volume of haemoglobin
 SpirometryForced expiratory volume in 1 s, forced vital capacity
 Exercise capacity6MWT
 Limited overnight polygraphyOutpatient SpO2 and HR; inpatient SpO2, TcCO2 and HR
 Sleep quality14-day actigraphy*
 Physical activity14-day actigraphy*
 CardiovascularBlood pressure and HR
Healthcare organisation-centred
 Health economicsHealthcare utilisation (total bed days, premium and standard nurse-interaction time, premium and standard doctor-interaction time, staff time for non-invasive ventilation set-up, frequency of setting changes, premium and standard nurse technical and nursing support postdischarge, outpatient appointments, outpatient reviews, telephone consultations, GP consultations, emergency care attendances costed as per standard treatment costs, equipment cost, hospital admissions)
  • *Measured using Philips Actiwatch spectrum.

  • 6MWT, 6 min walk test; BMI, body mass index; EQ-5D, EuroQol-5 dimensions; GP, general practitioner; HAD, hospital anxiety and depression; HCO3, arterial bicarbonate level; HR, heart rate; PaCO2, arterial partial pressure of carbon dioxide; PaO2, arterial partial pressure of oxygen; SpO2, oxygen saturation; SRI, severe respiratory insufficiency questionnaire; TcCO2, transcutaneous carbon dioxide level.